CLASS II Drug recall · Reported 23 Oct 2019 · FDA Enforcement Report

Leucovorin Calcium Injection, USP 500 mg* recalled

Ingenus Pharmaceuticals is recalling Leucovorin Calcium Injection, USP 500 mg*/ (10 mg/mL) Single-Dose Vial, distributed nationwide in the US. The recall was initiated on 9 Oct 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot#: 18048, 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020
Quantity recalled16485 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0146-2020
FDA event ID
84011
Recalling firm
Ingenus Pharmaceuticals, Orlando, FL
Classification
Class II
Status
Terminated
Recall initiated
9 Oct 2019
FDA classified
17 Oct 2019
Reported
23 Oct 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

9 Oct 2019Recall initiated by company
17 Oct 2019Classified by FDA+8 days
23 Oct 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Crystallization: Presence of particulate matter identified as API crystallization

Product as listed by the FDA

Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only Ingenus Pharmaceuticals, LLC. Orlando, FL 32839

Where it was distributed

U.S.A. Nationwide

Nationwide

Questions about this recall

Is Leucovorin Calcium Injection, USP 500 mg*/ (10 mg/mL) Single-Dose Vial recalled?

Yes. Ingenus Pharmaceuticals recalled Leucovorin Calcium Injection, USP 500 mg*/ (10 mg/mL) Single-Dose Vial on 9 Oct 2019. The recall is Class II and its status is Terminated. Recall number D-0146-2020.

Why was it recalled?

Crystallization: Presence of particulate matter identified as API crystallization

Which lots are affected?

Lot#: 18048, 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020

Where was it sold?

U.S.A. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ingenus Pharmaceuticals

All 6

Other Leucovorin recalls

All 11